November 4, 2016 09:35 AM EDT

Sanofi jumps into a pivotal study for next-gen Pompe drug

Arsalan Arif

Founder

Sanofi has added another badly-needed drug to its late-stage portfolio. The drug, dubbed neoGAA, is being advanced by its big Genzyme unit in Boston, which …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sanofi jumps into a pivotal study for next-gen Pompe drug

Arsalan Arif

Founder

Sign up to read this article for free.

Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

Pfizer shares positive Phase 3 results in breast cancer subset

The key to faster, more impactful research? Put patients in the driver’s seat

Sanofi jumps in­to a piv­otal study for next-gen Pompe drug

Arsalan Arif

Founder

Sign up to read this article for free.

Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

'Se­ri­ous liv­er in­jury' cas­es lead FDA to call for mon­i­tor­ing of Ocali­va pa­tients

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

Pfiz­er shares pos­i­tive Phase 3 re­sults in breast can­cer sub­set

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

Sanofi jumps into a pivotal study for next-gen Pompe drug

Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm

'Serious liver injury' cases lead FDA to call for monitoring of Ocaliva patients

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

Pfizer shares positive Phase 3 results in breast cancer subset

The key to faster, more impactful research? Put patients in the driver’s seat